MK

Mani Kanchan Paul

Director Managing Director DIN 07132215
DIN 07132215 First appointment Jun 2015 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Mani Kanchan Paul

Data last updated:

Mani Kanchan Paul was a Managing Director at Fabmed Biogenics And Mediquips Private Limited (2015–2017) and Director at Centriole Biogenics And Mediquips Private Limited (from 2017). The companies operate in Trading.

DIN 07132215
Primary Designation Managing Director
Industry Trading
First Appointment 16 Jun 2015
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director16 Jun 20152015₹1 Lakh (FY 2023)Active
Director31 Mar 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Centriole Biogenics And Mediquips Private Limited
Fabmed Biogenics And Mediquips Private Limited
Premium access

Shareholding and investment profile for Mani Kanchan Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mani Kanchan Paul

Mani Kanchan Paul was first appointed on 16 Jun 2015 as Managing Director at Fabmed Biogenics And Mediquips Private Limited. The most recent appointment on record is 31 Mar 2017 at Centriole Biogenics And Mediquips Private Limited.

Mani Kanchan Paul held 2 earlier board appointments: Fabmed Biogenics And Mediquips Private Limited (Managing Director, 16 Jun 2015 to 21 Sep 2017); Centriole Biogenics And Mediquips Private Limited (Director, from 31 Mar 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available